Advertising

NYSEARCA:IYH

286.37
1.30 (0.45%) 1d
0
Showing 1 to 13 of 13 entries
  • «
  • 1
  • »

Unlock the Monthly Gems

Become a member Or, Sign In
TOP PICK
The reason isn't that Biden will somehow boost this industry, but that without a Blue Wave the more left-leaning voices of the Democrats (Bernie Sander, Elizabeth Warren) won't have the power to demand healthcare reforms or lower drug prices. You can buy UnitedHealth or AbbVie, but they have popped 10.6% and 6.1% between Nov. 2-5 already. Johnson & Johnson? Thermo Fisher? Abbott Labs. All sound choices, but if you can't select just one, you can fall back on the iShares US Healthcare E.T.F. (IYH-N) which carries all these names, charges an MER of 0.43% and pays a 1.25% dividend yield. Like any ETF, your return won't be as high as some of the names its holds, but you also won't suffer the risk that those names carry. By the way, between Nov. 2-5, IYH rose 6.4%. Cannabis will get high.
E.T.F.'s
BUY
Allan Tong’s Discover Picks IYH stock tracks the Dow Jones U.S. healthcare sector and counts (in this order) Johnson & Johnson (9.05% weight), UnitedHealth Group, Merck, Pfizer, AbbVie, Abbott Labs and Thermo Fisher as its top holdings. IYH stock charges a 0.43% MER and pays a 1.21% dividend yield. Like many of its holdings, IYH stock offers a low beta (0.78). Average volumes are a little light at 69,000, but not a worry. YTD, IYH has climbed nearly 10%. Read NEE Stock and BABA Stock: 3 Savvy Election-proof Stocks for our full analysis.
E.T.F.'s
STRONG BUY
Healthcare and technology are the two leading groups. At this point you have to own healthcare. They have traded at a discount over the last 18 months. With all they have done going through this crisis, healthcare cuts are off the table. He owns a lot of healthcare names directly.
E.T.F.'s
COMMENT

He thinks the drivers behind the healthcare sector are as powerful today as they were 6 months ago. However, the environment has been changing, where you need to be more of an active manager, understanding which asset mix makes sense. This is a passive ETF, so you are subject to the whims of the largest names. You should have exposure to the sector, but try to identify something that is more actively managed.

E.T.F.'s
PAST TOP PICK

(A Top Pick July 3/15. Down 2.08%.) Sold about 2 months after he had picked it. Didn’t like what was happening in the US elections. Will probably look at getting back into a name like this in November.

E.T.F.'s
BUY

As we get closer to the US elections, this is probably a good time to start building a position.

E.T.F.'s
TOP PICK

A sleeping giant that he has had in his portfolio for a long time. He recommends that you read Byron Wien’s piece about innovation, biotech, healthcare. This ETF has great holdings. 40% exposure to pharmaceuticals, 25% exposure to the biotech sector, a well-rounded portfolio of names. In the past, these names have been thought of as a defensive kind of positioning, but feels they have slowly moved into the growthy areas of the markets, with huge innovations in medical and biotech. In a rising rate environment, if you are looking for something that is defensive but participates with a bit of growth, this might be a really attractive place to hide out.

E.T.F.'s
COMMENT

For the last decade investors have been thinking about healthcare and talking about demographics. For a long time healthcare companies in North America didn’t do much, but that really changed in the last 1.5-2 years. Thinks this is the beginning of a longer-term trend, and we will see continued growth in the healthcare industry. For a long-term proposition, this is not a bad place to be.

E.T.F.'s
COMMENT

Healthcare tends to be a little less correlated to the equity market, so it is an ideal place to be. We are approaching the seasonal strength for biotech at the end of June. The chart on this is showing higher lows and higher highs. A similar one, but hedged to the Cdn$, would be BMO Equal Weight US Healthcare (ZUH-T). (See Top Picks.)

E.T.F.'s
BUY

Owns all the large US healthcare names. Continues to move along at a very nice clip.

E.T.F.'s
BUY

This has big holdings in things like Johnson & Johnson (JNJ-N), Pfizer (PFE-N), Merck (MRK-N), etc. Has done very well year to date.

E.T.F.'s
BUY on WEAKNESS
Likes this area. Going forward, it will be a defensive space. Broke out past its previous resistance point. If you own, Hold. You could add to that on pullbacks.
E.T.F.'s
BUY
Have liked the sector for quite awhile. Has outperformed the S & P 500 since the beginning of the year. Very heavily weighted to large pharma. Short term there's a little bit of a risk, but long term, it's a place you want to have exposure to.
E.T.F.'s
Showing 1 to 13 of 13 entries
  • «
  • 1
  • »

iShares US Healthcare E.T.F.(IYH-N) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 1

Stockchase rating for iShares US Healthcare E.T.F. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

iShares US Healthcare E.T.F.(IYH-N) Frequently Asked Questions

What is iShares US Healthcare E.T.F. stock symbol?

iShares US Healthcare E.T.F. is a American stock, trading under the symbol IYH-N on the NYSE Arca (IYH). It is usually referred to as AMEX:IYH or IYH-N

Is iShares US Healthcare E.T.F. a buy or a sell?

In the last year, 1 stock analyst published opinions about IYH-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for iShares US Healthcare E.T.F..

Is iShares US Healthcare E.T.F. a good investment or a top pick?

iShares US Healthcare E.T.F. was recommended as a Top Pick by on . Read the latest stock experts ratings for iShares US Healthcare E.T.F..

Why is iShares US Healthcare E.T.F. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is iShares US Healthcare E.T.F. worth watching?

1 stock analyst on Stockchase covered iShares US Healthcare E.T.F. In the last year. It is a trending stock that is worth watching.

What is iShares US Healthcare E.T.F. stock price?

On 2021-09-24, iShares US Healthcare E.T.F. (IYH-N) stock closed at a price of $286.37.